← 返回首页
欧洲 · 综合新闻 · Swissinfo

Roche Drug Outshines Amgen, Bristol Rivals in Lung Cancer Study

来源:Swissinfo · 瑞士 9 小时前

A Roche Holding AG drug billed as a potential blockbuster helped patients with a form of lung cancer that had spread live almost six months longer than two competitive medicines.

在 Swissinfo 阅读全文 登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.swissinfo.ch)

推荐阅读